Liver Function Abnormalities in Patients With Acute Heart Failure
1 other identifier
observational
100
1 country
1
Brief Summary
The aim of this study is to evaluate liver function test abnormalities and to identify associated cardiac and non cardiac factors mediating hepatic impairment in acute heart failure patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedFirst Posted
Study publicly available on registry
July 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedJuly 10, 2024
July 1, 2024
1 year
July 1, 2024
July 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Liver function abnormalities in patients with acute heart failure in Sohag University Hospitals
assessment the LFTs abnormalities and factors mediating hepatic impairment in patients with AHF
baseline
Secondary Outcomes (1)
Liver function abnormalities in patients with acute heart failure in Sohag University Hospitals
1 year
Study Arms (5)
Acute decompensated heart failure (de novo or as decompensation of chronic heart failure)
This umbrella term includes patients presenting forthe first time with typical symptoms and signs of heart failure(de novo AHF) and also those with worsening of their pre-existing cardiomyopathy (acute decompensated heart failure).
Pulmonary edema
It's the real clinical presentation of AHF, typically, signs and symptoms develope rapidly and patients demonstrate severe respiratory distress with tachypnea, orthopnea and pulmonary congestion
Hypertensive acute heart failure
the condition is associated with elevated blood pressure with accompanying dyspnea. orthopnea and pulmonary congestion, often in patients with relatively preserved left ventricle ejection fraction
cardiogenic shock
severe peripheral hypoperfusion wih subsequent end organs damage,typically it's associated with low blood pressure and low urine output
Acute coronary syndrome complicated by heart failure
characterized by complex structural, hemodynamic and neurohormonal interaction need urgent referral for coronary intervention poor outcome
Interventions
Exercise, Salt and lipid reduction in diet, smoking cessation
Eligibility Criteria
patients aged 18 yrs or older presenting with AHF
You may qualify if:
- patients aged 18 yrs or older presenting with AHF
You may not qualify if:
- Congenital heart disease
- acute and chronic liver diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag university
Sohag, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hamdy Saad
Sohag University
- STUDY CHAIR
Haitham Mohammad
Sohag University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Liver function abnormalities in patients with acute heart failure in Sohag University Hospitals
Study Record Dates
First Submitted
July 1, 2024
First Posted
July 9, 2024
Study Start
July 1, 2024
Primary Completion
July 1, 2025
Study Completion
August 1, 2025
Last Updated
July 10, 2024
Record last verified: 2024-07